Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 773 of 1,261
  1. US 8933071

    Dimethyl fasudil for inducing polyploidization of megakaryocytes and for treating blood and bone marrow diseases and disorders

    Northwestern University · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  2. US 8932060

    Dental treatment method

    KURARAY NORITAKE DENTAL INC. · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  3. US 8932853

    Method for manufacturing pancreatic-hormone-producing cells

    Takeda Pharmaceutical Company Limited · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  4. US 8932561

    Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent

    Lutonix, Inc. · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  5. US 8933249

    3-(phenoxyphenylmethyl)pyrrolidine compounds

    Theravance Biopharma R&D IP, LLC · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  6. US 8933236

    N-substituted benzamides and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  7. US 8933216

    Immunosuppression compound and treatment method

    Sarepta Therapeutics, Inc. · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  8. US 8933201

    Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use

    The Board of Regents of the University of Oklahoma · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  9. US 8933193

    Lantibiotics and uses thereof

    Regents of the University of Minnesota · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  10. US 8933217

    Compounds, compositions, and methods for protecting brain health in neurodegenerative disorders

    Amazentis SA · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  11. US 8933111

    Crystalline form of (2S,4R)-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-4-[(1H-[1,2,3]triazole-4-carbonyl)-amino]-pentanoic acid 5-methyl-2-oxo-[1,3]dioxol-4-ylmethyl ester

    Theravance Biopharma R&D IP, LLC · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  12. US 8933076

    Pyridazine compounds, compositions and methods

    Northwestern University · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  13. US 8933110

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  14. US 8933105

    Pyrrole compounds

    Takeda Pharmaceutical Company Limited · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  15. US 8933069

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  16. US 8933047

    Poly(acrylate) polymers for in vivo nucleic acid delivery

    Arrowhead Madison, Inc. · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  17. US 8933031

    Polypeptide inhibiting angiogenesis and application thereof

    SHANGHAI FIRST PEOPLE'S HOSPITAL · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  18. US 8933041

    System for treating and preventing breast cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  19. US 8933030

    Treatments for gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  20. US 8932846

    Unmarked recombinant intracellular pathogen immunogenic compositions expressing high levels of recombinant proteins

    The Regents of the University of California · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  21. US 8932588

    Treatment of cancer involving mutated KRAS or BRAF genes

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  22. US 8932818

    Screening assays for compounds that modulate programmed ribosomal frameshifting

    PTC THERAPEUTICS, INC. · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  23. US 8932572

    Poly(vinyl ester) polymers for in vivo nucleic acid delivery

    Arrowhead Madison, Inc. · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  24. EP 2819679

    FLÜSSIGE FORMULIERUNGEN ENTHALTEND HYPOGLYZEMISCHE SULFAMIDE

    AMMTEK [FR] · Granted Jan 7, 2015 · Expires Jan 2, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.